We recorded a 7.3-fold mean decrease in salivary OXT levels in subjects with depression, aligning with findings focused on plasmatic levels of OXT and depression [23,24]. OXT's role in social bonding and stress regulation may explain its reduced levels in depressive disorders, and its consistent decrease suggests potential clinical applications in developing diagnostic tools or therapeutic interventions that target OXT pathways. This evidence concerns the gene OXT and depressive disorder.